Shire beats Street

Shire (LSE:SHP; SHPGY) posted second quarter non-GAAP earnings per ADS of $0.55, beating by $0.12 the Street's estimate of $0.43 and up 30% from $0.43 in the same period last year. The earnings per ADS figures exclude reorganization costs, a gain from an investment sale and the effect of a discontinued operation.

Revenues increased 8% quarter over quarter to $321.9 million. Sales of Adderall XR, a once-daily formulation of SHP's ADHD drug Adderall, came in at $143.5 million, up 40% from the second quarter of 2003. ...